Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001415889-25-012045

Director acquired 25,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Susman Robert Graham Director 2025-05-01 Grant or award +25,016 25,016 D
Derivatives
Susman Robert Graham Director 2025-05-01 Grant or award · Stock Option (Right to Buy) +35,234 35,234 D
Loading xslF345X05/form4-05052025_070501.xml…